Robert A Robbins

US Patent:

6605115, Aug 12, 2003

Filed:

Jun 5, 2000

Appl. No.:

09/587647

Inventors:

John P. Cooke - Palo Alto CA
Garrison C. Fathman - Portola Valley CA
Jonathan B. Rothbard - Woodside CA
Shiro Uemura - Nara, JP
Robert C. Robbins - Stanford CA
Murray H. Kown - Menlo Park CA

Assignee:

Board of Trustees of the Leland Stanford Junior University - Stanford CA

International Classification:

A61F 206

US Classification:

623 148, 623 142

Abstract:

Cardiovascular cell proliferation in a blood vessel subjected to trauma, such as angioplasty, vascular graft, anastomosis, or organ transplant, can be inhibited by contacting the vessel with a polymer consisting of from 6 to about 30 amino acid subunits, where at least 50% of the subunits are arginine, and the polymer contains at least six contiguous arginine subunits. Exemplary polymers for this purpose include arginine homopolymers 7 to 15 subunits in length.

US Patent:

20020029319, Mar 7, 2002

Filed:

Jun 6, 2001

Appl. No.:

09/876846

Inventors:

Robert Robbins - Sunnyvale CA, US
Richard Meyer - San Francisco CA, US
Jerry Smith - Long Beach CA, US

International Classification:

G06F012/00

US Classification:

711/114000, 711/156000

Abstract:

A system with a RAID controller connected to a plurality of hosts, and having a storage area configurable as a plurality of logical units. The RAID controller stores in an associated memory a table of access rights for the hosts to the logical units. Updates can be provided and additional material can be provided in new memory space that is subsequently made available to the various hosts by providing updated access rights that include the new space. In one embodiment, the present invention also maps the logical unit number from that requested by the host to an actual number used in the RAID subsystem.

US Patent:

20040074504, Apr 22, 2004

Filed:

May 20, 2003

Appl. No.:

10/442671

Inventors:

John Cooke - Palo Alto CA, US
Garrison Fathman - Portola Valley CA, US
Jonathan Rothbard - Woodside CA, US
Shiro Uemura - Nara, JP
Robert Robbins - Stanford CA, US
Murray Kown - Menlo Park CA, US

International Classification:

A61F002/06

US Classification:

128/898000, 623/916000

Abstract:

Cardiovascular cell proliferation in a blood vessel subjected to trauma, such as angioplasty, vascular graft, anastomosis, or organ transplant, can be inhibited by contacting the vessel with a polymer consisting of from 6 to about 30 amino acid subunits, where at least 50% of the subunits are arginine, and the polymer contains at least six contiguous arginine subunits. Exemplary polymers for this purpose include arginine homopolymers 7 to 15 subunits in length.

US Patent:

20060148700, Jul 6, 2006

Filed:

Nov 10, 2005

Appl. No.:

11/271285

Inventors:

Masashi Tanaka - Saitama-City, JP
Robert Robbins - Stanford CA, US

International Classification:

A01N 1/02

US Classification:

514012000, 435001100

Abstract:

Methods for reducing injury to a transplanted mammalian organ or tissue, including inhibiting the development of graft blood vessel disease, are provided. In one form, a method includes administering compositions that include one or more PKC regulators to an organ or tissue donor and an organ or tissue recipient. Methods for decreasing or otherwise modulating an inflammatory response in a mammal are also provided. In one form, a method includes administering one or more regulators of protein kinase C to a patient in need thereof prior to, during or after an event giving rise to an inflammatory response. Methods for inhibiting, or otherwise modulating, a pro-apoptotic event are also provided. In one form, a method includes administering a therapeutically effective amount of an agonist of ε protein kinase C, and optionally an inhibitor of δ protein kinase C.

US Patent:

20060159719, Jul 20, 2006

Filed:

Dec 20, 2005

Appl. No.:

11/316304

Inventors:

John Cooke - Palo Alto CA, US
Garrison Fathman - Portola Valley CA, US
Jonathan Rothbard - Woodside CA, US
Shiro Uemura - Palo Alto CA, US
Robert Robbins - Stanford CA, US
Murray Kown - Menlo Park CA, US

Assignee:

The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA

International Classification:

A61F 2/02

US Classification:

424423000, 514002000

Abstract:

Cardiovascular cell proliferation in a blood vessel subjected to trauma, such as angioplasty, vascular graft, anastomosis, or organ transplant, can be inhibited by contacting the vessel with a polymer consisting of from 6 to about 30 amino acid subunits, where at least 50% of the subunits are arginine, and the polymer contains at least six contiguous arginine subunits. Exemplary polymers for this purpose include arginine homopolymers 7 to 15 subunits in length.

US Patent:

20060167402, Jul 27, 2006

Filed:

Dec 20, 2005

Appl. No.:

11/316519

Inventors:

John Cooke - Palo Alto CA, US
Garrison Fathman - Portola Valley CA, US
Jonathan Rothbard - Woodside CA, US
Shiro Uemura - Palo Alto CA, US
Robert Robbins - Stanford CA, US
Murray Kown - Menlo Park CA, US

International Classification:

A61F 2/04

US Classification:

604008000, 514002000

Abstract:

Cardiovascular cell proliferation in a blood vessel subjected to trauma, such as angioplasty, vascular graft, anastomosis, or organ transplant, can be inhibited by contacting the vessel with a polymer consisting of from 6 to about 30 amino acid subunits, where at least 50% of the subunits are arginine, and the polymer contains at least six contiguous arginine subunits. Exemplary polymers for this purpose include arginine homopolymers 7 to 15 subunits in length.

US Patent:

20100113353, May 6, 2010

Filed:

Sep 8, 2009

Appl. No.:

12/584609

Inventors:

John P. Cooke - Palo Alto CA, US
Garrison C. Fathman - Portola Valley CA, US
Jonathan B. Rothbard - Woodside CA, US
Shiro Uemura - Palo Alto CA, US
Robert C. Robbins - Stanford CA, US
Murray H. Kown - Menlo Park CA, US

Assignee:

Leland Stanford Junior University - Palo Alto CA

International Classification:

A61K 38/16
A01N 1/02
A61K 38/08
A61K 38/10
A61P 9/00

US Classification:

514 12, 435 11, 514 16, 514 15, 514 17, 514 14, 514 13

Abstract:

Cardiovascular cell proliferation in a blood vessel subjected to trauma, such as angioplasty, vascular graft, anastomosis, or organ transplant, can be inhibited by contacting the vessel with a polymer consisting of from 6 to about 30 amino acid subunits, where at least 50% of the subunits are arginine, and the polymer contains at least six contiguous arginine subunits. Exemplary polymers for this purpose include arginine homopolymers 7 to 15 subunits in length.

US Patent:

20130029866, Jan 31, 2013

Filed:

Jul 20, 2012

Appl. No.:

13/554946

Inventors:

Ning Sun - Stanford CA, US
Michael T. Longaker - Stanford CA, US
Robert C. Robbins - Stanford CA, US
Joseph Wu - Stanford CA, US
Feng Lan - Menlo Park CA, US
Andrew Stephen Lee - Palo Alto CA, US
Paul W. Burridge - Stanford CA, US

International Classification:

C12Q 1/02
G01N 27/49
C40B 30/06
C12N 5/077
C40B 30/04
C40B 40/02
G01N 21/64
C12Q 1/68

US Classification:

506 9, 435 29, 435 612, 435366, 435 71, 435 611, 506 14, 506 10

Abstract:

Human somatic cells obtained from individuals with a genetic heart condition are reprogrammed to become induced pluripotent stem cells (iPS cells), and differentiated into cardiomyocytes for use in analysis, screening programs, and the like.